Sehgal, R.; de Mello, V.D.; Männistö, V.; Lindström, J.; Tuomilehto, J.; Pihlajamäki, J.; Uusitupa, M.
Indolepropionic Acid, a Gut Bacteria-Produced Tryptophan Metabolite and the Risk of Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease. Nutrients 2022, 14, 4695.
https://doi.org/10.3390/nu14214695
AMA Style
Sehgal R, de Mello VD, Männistö V, Lindström J, Tuomilehto J, Pihlajamäki J, Uusitupa M.
Indolepropionic Acid, a Gut Bacteria-Produced Tryptophan Metabolite and the Risk of Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease. Nutrients. 2022; 14(21):4695.
https://doi.org/10.3390/nu14214695
Chicago/Turabian Style
Sehgal, Ratika, Vanessa D. de Mello, Ville Männistö, Jaana Lindström, Jaakko Tuomilehto, Jussi Pihlajamäki, and Matti Uusitupa.
2022. "Indolepropionic Acid, a Gut Bacteria-Produced Tryptophan Metabolite and the Risk of Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease" Nutrients 14, no. 21: 4695.
https://doi.org/10.3390/nu14214695
APA Style
Sehgal, R., de Mello, V. D., Männistö, V., Lindström, J., Tuomilehto, J., Pihlajamäki, J., & Uusitupa, M.
(2022). Indolepropionic Acid, a Gut Bacteria-Produced Tryptophan Metabolite and the Risk of Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease. Nutrients, 14(21), 4695.
https://doi.org/10.3390/nu14214695